Coxiella burnetii is a gram-negative intracellular bacterium that forms a large, lysosome-like parasitophorous vacuole (PV) essential for bacterial replication. Host membrane lipids are critical for the formation and maintenance of this intracellular niche, yet the mechanisms by which Coxiella manipulates host cell lipid metabolism, trafficking and signalling are unknown. Oxysterol-binding proteinrelated protein 1 long (ORP1L) is a mammalian lipid-binding protein that plays a dual role in cholesterol-dependent endocytic trafficking as well as interactions between endosomes and the endoplasmic reticulum (ER). We found that ORP1L localized to the Coxiella PV within 12 h of infection through a process requiring the Coxiella Dot/Icm Type 4B secretion system, which secretes effector proteins into the host cell cytoplasm where they manipulate trafficking and signalling pathways. The ORP1L N-terminal ankyrin repeats were necessary and sufficient for PV localization, indicating that ORP1L binds a PV membrane protein. Strikingly, ORP1L simultaneously co-localized with the PV and ER, and electron microscopy revealed membrane contact sites between the PV and ER membranes. In ORP1L-depleted cells, PVs were significantly smaller than PVs from control cells. These data suggest that ORP1L is specifically recruited by the bacteria to the Coxiella PV, where it influences PV membrane dynamics and interactions with the ER.
Introduction
Intracellular bacterial pathogens hijack host cell processes as a mechanism to create or modify their intracellular niche. In the case of pathogens that reside in membrane-bound compartments, membrane and membrane lipids are obtained from the host cell through a variety of mechanisms. One strategy, used by Legionella pneumophila and Brucella spp., is to recruit membrane directly from an organelle such as the endoplasmic reticulum (ER) (Swanson and Isberg, 1995; Pizarro-Cerda et al., 1998) . Other pathogens such as Chlamydia trachomatis intercept ceramide and cholesterol trafficking from the ER and Golgi, respectively, using these lipids as building blocks for the bacteria-containing compartment (Hackstadt et al., 1995; Carabeo et al., 2003; Derre et al., 2011; Elwell et al., 2011) . A third strategy, used by the Q fever agent Coxiella burnetii, is to create a compartment that interacts with a wide range of host vesicular trafficking pathways (Moffatt et al., 2015) . Upon infection, nascent C. burnetii-containing vacuoles mature into acidic phagolysosomes by trafficking through the default endocytic pathway, a process essential for formation of a mature parasitophorous vacuole (PV) that supports growth (Heinzen et al., 1996) . Early during infection, C. burnetii acquires the autophagic marker LC3, and early interactions with the host autophagy pathway enhance PV development and bacterial growth (Beron et al., 2002; Gutierrez et al., 2005; Newton et al., 2014) . Approximately 24-48 h after infection, the C. burnetii PV expands, fusing with early and late endosomes, lysosomes and autophagosomes (Voth and Heinzen, 2007) . The PV contains the late endosomal markers CD63 and Rab7 (Beron et al., 2002; Ghigo et al., 2002) , lysosomal-associated membrane protein 1 (Lamp1) (Heinzen et al., 1996) , autophagic markers LC3 and Rab24 (Beron et al., 2002; Gutierrez et al., 2005) and the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins Vamp2, Vamp7, Vamp8 and Vti1b (Campoy et al., 2013) . Further, both clathrin-mediated vesicular trafficking and retrograde trafficking play a role in PV development (Larson et al., 2013; McDonough et al., 2013) . The mature PV, however, does not appear to fuse directly with early endosomes or the Golgi apparatus, based on the lack of markers for these organelles on the PV membrane (Heinzen et al., 1996; Howe et al., 2003) .
Coxiella burnetii actively directs PV formation through a Dot/Icm type 4B secretion system (T4BSS), which secretes bacterial effector proteins into the host cell cytoplasm. In the absence of a functional T4BSS, PV expansion and robust bacterial replication do not occur (Carey et al., 2011; Beare et al., 2012) . Activation of the T4BSS requires the acidic environment of a late endosome/lysosome, with effector secretion detectable by 8 h post infection . Effector proteins have been localized to several major host cell structures, with a subset known as Coxiella vacuolar proteins (Cvp) also localizing to the C. burnetii PV (Larson et al., 2013; Larson et al., 2015) . Mutants in any one of the five PV-localized Cvp effectors show reduced intracellular replication, indicating that bacterial proteins on the PV membrane are required to maintain an intracellular niche that supports C. burnetii growth (Larson et al., 2015) .
In addition to a unique protein profile, the PV membrane contains a high sterol concentration, as evident by staining with the fluorescent sterol-binding compound filipin (Howe and Heinzen, 2006; Gilk, 2012) . Further, altering cholesterol homeostasis has a dramatic impact on PV formation and bacterial growth (Howe and Heinzen, 2006; Czyz et al., 2014) , thus indicating that cholesterol plays an important, yet unknown, role in Coxiella pathogenesis. In addition to its role in membrane fluidity, cholesterol regulates membrane trafficking and signalling through a large family of sterol sensor and transfer proteins. One member of this family, oxysterol-binding protein-related protein 1 long, or ORP1L, plays a major role in cholesterol-dependent endosomal trafficking and formation of membrane contact sites (MCS) between late endosomes/lysosomes and the ER. ORP1L undergoes cholesterol-dependent conformational changes that regulate interactions between endosomes and either microtubules or the ER. On cholesterol-rich endosomes, ORP1L adopts a compact conformation with the N-terminal ankyrin repeats binding the Rab7-RILP (Rab-interacting lysosomal protein) complex and the C-terminal oxysterolbinding protein-related domain (ORD) binding cholesterol (Rocha et al., 2009 ). When ORP1L is in this conformation, RILP is free to bind the homotypic fusion and protein sorting tethering (HOPS) complex, which in turn binds the motor protein dynein to facilitate minus end-directed transport of endosomes along microtubules (van der Kant et al., 2013a) . On low cholesterol membranes, the absence of ORD binding to cholesterol results in an extended ORP1L conformation, allowing the two phenylalanines in an acidic tract (FFAT) motif to interact with the resident ER protein VAMP-associated ER protein (VAP). As a result of binding to both the ER and late endosomes/lysosomes, ORP1L forms MCS between these two organelles and disrupts association between RILP and microtubules (Rocha et al., 2009) . Related to its role in late endosome trafficking, ORP1L has roles in transport of low-density lipoprotein cholesterol to the ER (Cianciola et al., 2013) , multivesicular body formation and membrane protein degradation (Kobuna et al., 2010) . These roles in lipid trafficking may additionally influence transcriptional regulation of cholesterol efflux genes (Johansson et al., 2003) .
Given the cholesterol-dependent role of ORP1L in late endosome and lysosome trafficking, we examined ORP1L localization during C. burnetii host cell infection. Here, we show that ORP1L localizes to the C. burnetii PV, a process dependent on the C. burnetii T4BSS. Despite the high PV sterol content, ORP1L does not primarily bind PV membrane cholesterol, but instead a PV membrane protein through the N-terminal ankyrin repeats. Furthermore, ORP1L simultaneously associates with both the PV and ER, demonstrating for the first time a direct link between these two organelles. Finally, ORP1L depletion with siRNA results in smaller PVs compared with PVs from wild-type cells, suggesting that ORP1L plays a role in PV expansion.
Results

ORP1L localization to the C. burnetii parasitophorous vacuole is T4BSS-dependent
We first examined ORP1L localization in uninfected and infected HeLa cells expressing ORP1L fused to green fluorescent protein (GFP). By live cell microscopy, ORP1L-GFP localized to small vesicular structures in uninfected cells (Fig. 1A) , consistent with published observations that ORP1L is found on endosomes (Johansson et al., 2003) . In C. burnetii-infected cells, ORP1L-GFP also localized to the C. burnetii PV (Fig. 1A, arrow) . PV localization was confirmed by indirect immunofluorescence, where ORP1L-GFP co-localized with the PV marker CD63 (Fig. 1B, arrow) . We observed identical localization for both N-terminal and C-terminal GFP fusion proteins (Fig. S1 ).
The C. burnetii T4BSS transports bacterial effector proteins across the PV membrane and into the host cell cytoplasm, where they manipulate host cell functions such as vesicular trafficking and apoptosis (reviewed in Moffatt et al., 2015) . T4BSS effector proteins recruit several host cell proteins to the PV, including clathrin (Larson et al., 2013) and LC3 (Winchell et al., 2014) . To determine if the T4BSS is involved in ORP1L PV localization, we examined ORP1L-GFP-expressing cells infected with either wild-type C. burnetii or a C. burnetii mutant lacking IcmD, an essential component of the T4BSS (Beare et al., 2011) . The cells were fixed and stained for C. burnetii and Lamp1, a lysosomal protein that also serves as a marker for the C. burnetii PV. Unlike PVs harbouring wild-type bacteria, ORP1L-GFP did not localize to PVs containing the IcmD mutant ( Fig. 2A ). When quantified, over 85% of wild-type PVs were ORP1L-positive by 24 h post infection, with nearly 95% being positive by 48 h (Fig. 2B) . In contrast, less than 10% of the IcmD mutant PVs were positive at any point during a 72 h infection, demonstrating that the T4BSS is required for ORP1L localization to the C. burnetii PV.
ORP1L recruitment occurs prior to PV expansion T4BSS-dependent localization of ORP1L to the PV could occur either through fusion with endosomes or through direct recruitment by a PV-associated protein. ORP1L does not contain transmembrane domains, and membrane association requires binding to membrane proteins or lipids. We therefore hypothesized that ORP1L interacts with the PV by protein-protein or protein-lipid interactions and is not delivered through membrane fusion events during PV expansion. To test this, we assessed the timing of PV expansion in comparison with ORP1L PV localization. To determine when PV expansion occurs in HeLa cells, we measured PVs harbouring either wild-type or IcmD mutant bacteria during a 72 h infection time course (Fig. 2C) . PVs harbouring IcmD mutant bacteria never expanded, consistent with the role of the T4BSS in PV fusion and expansion. For wild-type bacteria, a small amount of expansion was observed by 24 h, with the vast majority of PVs expanding between 24 and 48 h. At 48 h post infection, there was a small but statistically significant difference in PV size between untransfected and ORP1L-GFP transfected cells (Fig. S2) . However, the timing of expansion was identical, suggesting that the ectopic expression of ORP1L-GFP does not affect the overall timing of expansion. When PV size was compared with ORP1L PV localization in wild-type PVs, ORP1L was present on the PV prior to significant expansion (Fig. 2D) . Furthermore, ORP1L recruitment was independent of PV size, as wild-type ORP1L-positive PVs were nearly identical in size to IcmD mutant ORP1L-negative PVs at early time points (Fig. 2D ). Based on these data, we hypothesize that ORP1L is directly recruited by a PV membrane protein or lipid prior to PV expansion.
ORP1L ankyrin repeats are necessary and sufficient for PV localization ORP1L contains multiple domains responsible for both protein-protein interactions and protein-lipid interactions (Fig. 3A) . Three N-terminal ankyrin repeats interact with the small GTPase Rab7 (Johansson and Olkkonen, 2005b) . ORP1L association with the ER is mediated through an FFAT motif that binds the ER protein VAP (Rocha et al., 2009) . The plekstrin homology (PH) domain binds with low affinity and specificity to the signalling lipids PI(3,4)P 2 and PI(3,4,5)P 3 (Johansson et al., 2005a) , while the C-terminal ORD binds cholesterol and several oxysterol species (Yan et al., 2007; Vihervaara et al., 2011) . To identify the ORP1L domain(s) responsible for PV localization, we generated GFP fusions of the ORP1L domains and assessed their localization using live cell imaging of C. burnetii-infected cells (Fig. 3B ). Like wild-type ORP1L, ORP1L with a mutated FFAT motif localized to the PV. Removal of the cholesterolbinding domain (ΔORD) did not alter the PV localization, and the ORD domain by itself was cytoplasmic, indicating that cholesterol is not significantly involved in ORP1L PV localization. In addition to cholesterol, the signalling lipids PI (3,4)P 2 and PI(3,4,5)P 3 also appear to not be sufficient for PV localization, as GFP fusions of the phosphoinositidebinding PH domain were also cytoplasmic, with virtually no PV association. In contrast, PV localization was observed for both the ORP1L ankyrin repeat domain along with the PH domain (Ank-PH) and the ORP1L ankyrin repeat domain alone (Ank). To determine if the ankyrin repeats are required for PV association, we generated an ORP1L ankyrin truncation mutant (ΔAnk). ΔAnk-GFP did not localize to the PV and was cytoplasmic, demonstrating that the N-terminal ankyrin repeats are necessary and sufficient for ORP1L association with the PV. Further, these data show that protein-protein interactions, and not protein-lipid, are primarily responsible for ORP1L PV localization.
ORP1L can simultaneously associate with the C. burnetii PV and host endoplasmic reticulum Using confocal microscopy to more precisely define ORP1L localization on the PV membrane, we observed a striking ER-like reticulate pattern most clearly seen when looking at the top surface of the PV (Fig. 4A) . ORP1L contains an FFAT motif, a conserved protein motif which binds to VAP on the cytosolic surface of the ER (Kaiser et al., 2005) . We hypothesized that the PV ORP1L reticulate pattern was due to ORP1L also interacting with the ER via the FFAT motif. To test this, we mutated the FFAT motif such that it could no longer bind to VAP and examined the ORP1L pattern on the C. burnetii PV. While the ORP1L FFAT mutant still localized to the PV (Figs 3B and 4A), the reticulate pattern was lost (Fig. 4A, bottom panel) , suggesting that PV-associated ORP1L also binds to VAP on the ER. To further confirm this observation, we tested for co-localization between PVassociated ORP1L and the ER marker KDEL-RFP (red fluorescent protein). We observed significant overlap between PV-associated ORP1L-GFP and KDEL-RFP (Fig. 4B) , demonstrating that ORP1L can simultaneously interact with both the PV and the ER. Together with the domain studies, these data suggest that PV-associated ORP1L binds to a PV membrane protein via the ankyrin repeats, while the FFAT motif binds to VAP on the ER cytosolic surface.
Membrane contact sites between the PV and ER
The finding that ORP1L simultaneously associates with both the PV and the ER suggests the presence of MCS between these two membranes. MCS are sites where membranes closely interact with an intermembrane distance of~15 nm or the length of a single protein. Given that this is the first indication of MCS between the C. burnetii PV and ER, we used transmission electron microscopy (TEM) and electron tomography to more closely define the interactions between these two membranes. By TEM, the ER was found in close apposition to the PV membrane at several sites in HeLa cells (Fig. 5) . We also observed close interactions between the PV and ER in Vero epithelial cells and THP-1 macrophage-like cells (Fig. S4) , indicating that this interaction is not cell-type specific. Using electron tomography to generate a higher resolution three-dimensional structure, we identified numerous PV-ER MCS with less than 3 nm distance between the two membranes as well as sites where the PV and ER appear to be in direct contact (Fig. S4 and Movies S1-3). These data demonstrate the presence of membrane contact sites between the C. burnetii PV and the host endoplasmic reticulum.
ORP1L depletion leads to smaller PVs
To further understand the role of ORP1L during C. burnetii colonization of host cells, we used an ON-TARGETplus siRNA pool to deplete ORP1L. ORP1L protein levels were decreased by 90% at the time of infection, with levels remaining less than 30% of non-targeting control siRNA for the duration of a 6 day infection time course (Fig. 6A) . At 2 and 3 days post infection, the PV size in ORP1L-depleted cells was similar to the control cells (Fig. 6B) . However, while the control PVs continued to expand approximately four-fold between days 3 and 6, the PVs in ORP1L-depleted cells had significantly less expansion and were half the size of nontargeting PVs at day 6. Similarly sized PVs were observed at day 6 post infection in the cells treated with a single siRNA duplex (Fig. S3) . Interestingly, C. burnetii growth was similar in the cells treated with nontargeting or ORP1L siRNA (Fig. 6C) . RILP and Rab7 localize to the C. burnetii PV in both normal and ORP1L-depleted cells (Fig. S6) , indicating that the smaller PVs in the ORP1L-depleted cells are not due to the absence of Rab7 or RILP from the PV. These data suggest that ORP1L plays a role in PV size; further, a large, spacious PV is not required for robust bacterial growth.
Discussion
The endoplasmic reticulum plays essential roles in mammalian cells, including lipid and protein synthesis, calcium storage and the cellular stress response. MCS between the ER and other cellular organelles serve as a location for exchange of small molecules and lipids. The formation of MCS relies on multi-protein complexes that tether the two membranes together within a distance of 15 nm (Phillips and Voeltz, 2016) . Prior studies have implicated ORP1L, a member of the sterol transfer protein family, in the formation of late endosome/lysosome-ER MCS (Rocha et al., 2009; Weber-Boyvat et al., 2015) . In this study, we discovered that ORP1L also localizes to the PV harbouring the intracellular bacterial pathogen C. burnetii. ORP1L can simultaneously bind to the C. burnetii PV and the ER, suggesting that ORP1L is a component of PV-ER MCS. This is the first description of MCS between the C. burnetii PV and an intracellular organelle and is supported by a recent study showing that the ER marker calnexin is closely associated with the PV during C. burnetii infection (Graham et al., 2015) . ORP1L depletion results in smaller PVs, indicating that ORP1L plays a role in PV membrane dynamics.
Our data show that ORP1L localization to the C. burnetii PV requires both the N-terminal ankyrin repeats and a functional C. burnetii T4BSS. The requirement for the ankyrin repeats indicates that protein-protein interactions are primarily responsible for ORP1L association with the PV. This is true for ORP1L localization during adenovirus infection, where the adenovirus protein RIDα binds to ORP1L in the formation of endosome-ER MCS (Cianciola et al., 2013) . Several C. burnetii T4BSS effector proteins localize to the PV membrane (Larson et al., 2013) and are potential binding partners for ORP1L. In an analogous system, the C. trachomatis protein IncD recruits the ceramide-transfer protein CERT to the bacterial inclusion, which in turn binds VAP on the ER to form inclusion-ER MCS (Derre et al., 2011; Elwell et al., 2011) . Thus, intracellular pathogens may have a common strategy to recruit host cell proteins in the formation of MCS with the ER. A. Live cell confocal microscopy images of ORP1L-GFP on the C. burnetii PV. HeLa cells were transfected with wild-type ORP1L-GFP or an FFAT mutant, ORP1L(D478A)-GFP. Three days after infection with mCherry-expressing C. burnetii, the PVs were identified by phase microscopy and fluorescence imaged by live cell spinning disk confocal microscopy. When the top surface of the PV is examined, wild-type ORP1L exhibits a striated pattern. This pattern is disrupted by the FFAT D478A mutation, which prevents binding to the ER protein VAP. B. Live cell fluorescence microscopy images of C. burnetii-infected HeLa cells expressing ER-localized red fluorescent protein and ORP1L-GFP. The maximum Z projection shows the flattened confocal stack through the entire cell, while the PV surface is a confocal slice of the top surface of the PV (arrow). As shown in the magnification of the boxed PV, ORP1L-GFP on the PV co-localized with the host ER. Red = ER, Green = ORP1L-GFP. Scale bars = 10 μm.
Besides directly binding a T4BSS effector, a T4BSS effector protein might modulate the small GTPase Rab7, the ORP1L binding partner on late endosomes and lysosomes (Johansson and Olkkonen, 2005b) . Rab7 cycles between an active GTP-bound form and an inactive GDP-bound form. ORP1L can bind both forms and stabilizes GTP-bound Rab7, although it is not known if the Rab7 activation state affects ORP1L function (Johansson et al., 2005a) . A constitutively active mutant of Rab7 is found on the PV (Beron et al., 2002) , and Rab7 is required for PV maturation and expansion through an unknown mechanism (Beron et al., 2002; Newton et al., 2013) . It is possible that a T4BSS effector protein regulates Rab7 activation, leading to the recruitment of ORP1L. We also cannot rule out the possibility that the lack of ORP1L on IcmD mutant PVs is indirectly due to a lack of PV maturation. However, because PVs harbouring the IcmD mutant do support limited bacterial replication (Beare et al., 2011) , maturation to an acidic phagolysosome is most likely not the sole requirement for PV ORP1L localization. This is further supported by ORP1L localization to the majority of wild-type C. burnetii PVs at 12 h post infection, shortly after T4BSS secretion is believed to begin around 8 h post infection. Further studies are needed to identify the ORP1L PV binding partner(s) and understand how ORP1L is recruited to the PV membrane.
ORP1L exhibited a striated pattern on the C. burnetii surface that co-localized with an ER marker; this ER-like pattern was lost when the ORP1L FFAT motif was mutated. FFAT motifs bind to VAP on the ER cytosolic surface, and ORP1L has been shown to directly bind VAP (Weber-Boyvat et al., 2015) . Based on these data, we propose a model where PV-associated ORP1L binds to VAP on the ER, forming MCS between the PV and ER (Fig. 7) . This model is further supported by our observation of PV-ER MCS by electron microscopy. While our data suggest that ORP1L and VAP are components of these MCS, other proteins or protein complexes may be involved, and ORP1L may not be a component of every PV-ER MCS. Indeed, many lipid transfer proteins with FFAT motifs have been found at MCS between the ER and the plasma membrane, Golgi and mitochondria (reviewed in Kentala et al., 2016) .
ORP1L depletion led to smaller PVs, yet did not have an effect on bacterial growth. A similar observation was made recently in Lamp 1/2 knockout fibroblasts (SchulzeLuehrmann et al., 2016) , suggesting that a large, spacious PV is not essential for C. burnetii growth. Further, a mutant in the Coxiella T4SS effector protein CvpB forms multiple PVs per cell but does not have a growth defect in vitro (Newton et al., 2014; Martinez et al., 2016) . Collectively, Coxiella appears to modulate a complex interplay of different, and possibly redundant, pathways to build the optimal vacuole to support bacterial replication. This is supported by the finding that a CvpB mutant has an attenuated virulence phenotype in the in vivo insect model Galleria mellonella (Martinez et al., 2016) . The reason behind smaller PVs in the absence of ORP1L is not clear. Interactions between host vesicular trafficking and the PV membrane are not well understood, but it has been assumed that a significant portion of the PV membrane comes from fusion with host vesicles. It is possible that the ER might serve to stabilize the PV membrane, with the absence or decrease in PV-ER MCS leading to altered PV membrane dynamics and decreased fusion with host trafficking pathways. Alternatively, ORP1L may play a direct role in fusion between the PV and host cell endosomes, and smaller PVs might be the result of decreased fusion. In uninfected cells, ORP1L regulates endosomal tethering and subsequent fusion by mediating interactions between RILP and the HOPS complex (van der Kant et al., 2013a) . Both Rab7 and RILP localize to the C. burnetii PV in the absence of ORP1L, suggesting that these proteins are not directly responsible for the size defect. Given the dual role of ORP1L in endosomal fusion and endosome-ER membrane contact sites, further investigation of the molecular machinery involved in endosome-PV fusion is needed.
The function of ORP1L and PV-ER MCS is not clear. ORP1L belongs to a family of sterol-transfer proteins and binds phosphatidylinositol phosphates, oxysterols and cholesterol. ORP1L may transfer cholesterol or other sterols between two membranes, similar to the proposed function of CERT at the C. trachomatis inclusion (Derre et al., 2011; Elwell et al., 2011) . ORP1L is hypothesized to transfer cholesterol from lysosomes to the ER, independent of the lysosomal cholesterol transporter NPC1, with the cholesterol then incorporated into lipid droplets (Cianciola et al., 2013; van der Kant et al., 2013b) . PV-ER MCS may also participate in the exchange of calcium or other small molecules or be a mechanism to manipulate ER stress and apoptosis.
In summary, this study demonstrates the presence of membrane contact sites between the C. burnetii PV and the host ER. The sterol-binding protein ORP1L is one component of these MCS and appears to play a role in PV membrane dynamics. Future experiments identifying the PV binding partner and elucidating the function of PV-ER interactions will give new insight into C. burnetii pathogenesis and manipulation of the host cell.
Experimental procedures
Bacteria and mammalian cells
Coxiella burnetii Nine Mile Phase II (NMII; clone 4, RSA439) and mCherry-expressing C. burnetii NMII (Beare et al., 2009) were purified from African green monkey kidney epithelial cells (Vero cells, ATCC CCL-81; American Type Culture Collection, ATCC, Manassas, VA, USA) and stored as previously described (Cockrell et al., 2008) . For experiments examining T4BSS-dependent recruitment of ORP1L, NMII and the IcmD mutant (Beare et al., 2011) were grown for 4 days in ACCM-2, washed twice with phosphate buffered saline (PBS) and stored as previously described ). The multiplicity of infection for each bacteria stock was optimized for~1 internalized bacterium per cell. Vero, human cervical epithelial cells (HeLa; ATCC CCL-2) and human monocytes (THP-1; ATTC TIB-202) were maintained in RPMI (Roswell Park Memorial Institute medium) 1640 medium (Corning, New York, NY, USA) containing 10% fetal bovine serum (Atlanta Biologicals, Norcross, GA, USA) at 37°C and 5% CO 2 . THP-1 cells were differentiated with 200 nM of phorbol 12-myristate 13-acetate for 24 h. The phorbol 12-myristate 13-acetate was removed, and the cells rested for 48 h prior to infection. Recruitment and PV measurements For PV size measurements, each PV was imaged, and the crosssectional area through the middle of the PV was measured with IMAGEJ software (NIH).
Live cell microscopy
For localization of ORP1L domain GFP constructs, HeLa cells were transfected and infected with mCherry-expressing C. burnetii, as described in the preceding texts. At 3 days post infection, the cells were replated onto ibidi u-Dishes (ibidi, Verona, WI, USA) and visualized live using the Leica inverted microscope described in the preceding texts. For ER localization studies, the cells were transduced with the ER marker KDEL-RFP CellLights BacMam (Invitrogen; multiplicity of infection of 10) 24 h prior to imaging on a modified Perkin-Elmer UltraView spinning-disk confocal system connected to a Nikon Eclipse Ti-E inverted microscope with a 100× objective and environmental chamber for temperature and CO 2 control (Pathology Devices, Inc., Westminster, MD, USA).
Transmission electron microscopy
The infected cells grown in six-well plates were fixed with 2.5% glutaraldehyde/0.5 M of sucrose in 0.1 M of sodium cacodylate pH 6.8. The samples were processed and visualized at 80 kV with a model H7500 electron microscope as previously described (Starr et al., 2012) .
Electron tomography
Samples were prepared as described in the section on Transmission Electron Microscopy. Sections (200 nm) were collected on glowdischarged carbon grids, and 10 colloidal gold fiducial markers were applied. Using a linear tilt scheme, single-axis tilt series were collected on a Tecnai BioTwin Spirit TEM (FEI) operated at 120 kV. Images captured over a tilt range of ±68°(1°increments) at 1 μm defocus were recorded on a 2048 × 2048 pixel UltraScan 1000 Gatan CCD camera using the automated tomography acquisition software (Xplore 3D, FEI, Hillsboro, OR, USA)). The tilt series were aligned using the Imod software package (version 4.8.40). All measurements were carried out using the Amira Visualization Package (version 6.0.0, FEI).
siRNA knockdown ORP1L and non-targeting ON-TARGETplus SMARTpool siRNA duplexes were obtained from GE Dharmacon (Lafayette, CO, USA).
HeLa cells (1.2 × 10 5 cells) were transfected with 50 nM of siRNA in six-well plates using DharmaFECT 1, according to the manufacturer's reverse transfection protocol (GE Dharmacon). Two days later, the cells were infected with C. burnetii for 1 h as described in the preceding texts, trypsinized and re-transfected with 50 nM of siRNA in 24-well plates (2.5 × 10 4 cells per well). At the given time points, the wells were processed for immunoblotting, fluorescent foci 
Fluorescent infectious foci-forming unit assay
To quantitate bacterial growth in HeLa cells, fluorescent foci unit assays were performed as previously described (Coleman et al., 2004) . Briefly, bacteria were released from infected HeLa cells by incubating for 5 min in sterile water, followed by serial dilutions in 2%
RPMI and addition to Vero cell monolayers in 24-well plates. After 5 days, the cells were fixed with methanol and stained with rabbit anti-C. burnetii and Alexa488 secondary antibodies. Fluorescent foci were visualized using an Evos FL Auto Imaging System (ThermoScientific) and counted using ImageJ. Each experiment was performed in duplicate.
Data analysis
Image processing and analysis was performed with ImageJ software (W.S. Rasband, National Institutes of Health, Bethesda, MD, USA). Statistical analyses were performed using unpaired Welch's t-test or ordinary one-way ANOVA with Sidak multiple comparisons tests in Prism (GraphPad Software, Inc., La Jolla, CA, USA).
Fig. S1
. GFP-ORP1L localization. Live cell confocal microscopy image of C. burnetii-infected HeLa cell expressing GFP-ORP1L. GFP-ORP1L localizes to the C. burnetii PV (arrow).
The cell boundary is outlined. Scale bar = 10 μm. Fig. S2 . PV size in ORP1L-GFP expressing cells. At 48 h post infection, wild-type PVs in cells ectopically expressing ORP1L-GFP are smaller than untransfected cells. Error bars represent SEM. Means were compared by ordinary one-way ANOVA with Sidak's multiple comparisons tests. ** = p < 0.01. Fig. S3 . Depletion of ORP1L with single siRNA duplex results in smaller PVs. HeLa cells were treated with a single siRNA duplex at 50 nM. At 6 days post infection, coverslips were fixed with paraformaldehyde, and the PV membrane was stained with anti-CD63 and anti-C. burnetii. The PV size was determined using ImageJ and means compared by unpaired Welch's t-test. The scatter plot shows individual PV measurements from two experiments, with at least 40 PVs per condition in each experiment. Bars indicate average ± SEM. **** = p < 0.0001. Fig. S4 . PV-ER membrane contact sites in C. burnetii-infected Vero and THP-1 cells. Vero and THP-1 cells were infected with C. burnetii, fixed at 1 day post infection (THP-1) or 2 days post infection (Vero) and analysed by transmission electron microscopy. Multiple membrane contact sites between the PV and ER are observed (boxed magnification, arrows). Fig. S5 . Measurement of PV-ER membrane contact sites using electron tomography. HeLa cells were infected with C. burnetii and examined by electron tomography at 2 days post infection. Shown are slices from Movie S1. The boxed areas are further magnified, and the distances between the PV (blue line) and ER membranes (red lines) are shown. In a, the PV and ER membranes are indistinguishable (arrow), while b-d show areas where the two membranes are less than 3 nm apart. Scale bar = 50 nm. Fig. S6 . Depletion of ORP1L does not alter Rab7 and RILP PV-localization. HeLa cells were treated with siRNA, transfected with plasmid DNA the next day and then infected 1 day later. At 2 days post infection, cells were fixed and stained for CD63 and Coxiella. Both Rab7-GFP (A) and RIL-GFP (B) localize to the Coxiella PV in cells treated with siRNA targeting ORP1L or non-targeting (NT) negative control. Scale bar = 10 μm. Movies S1-3. Electron tomography tilt series of three different C. burnetii PVs. Tilt series for three separate PVs are shown; the arrow denotes areas where the PV and ER membranes are indistinguishable from one another.
